Literature DB >> 28667566

Connecting Gaucher and Parkinson Disease: Considerations for Clinical and Research Genetic Counseling Settings.

Lola Cook1, Jeanine Schulze2.   

Abstract

There are multiple autosomal recessive disorders in which carriers may be at risk for other diseases. This observation calls into question the previous understanding that carriers of autosomal recessive disorders escape clinical consequences. We also know that childhood genetic conditions may have adult disease counterparts (Zimran et al., The Israel Medical Association Journal: IMAJ, 16(11), 723-724, 2014). Individuals who have Gaucher disease and carriers of the disorder are at increased risk for a seemingly unrelated and complex neurological condition, Parkinson disease. Parkinson disease is, in part, caused by the same mutations in the GBA gene that lead to Gaucher disease, and the two conditions are thought to have shared pathophysiology. Briefly reviewed are how these two diseases historically became linked, where their paths cross, potential problems and considerations in disclosure of the link, and current guidelines and research in this area. Genetic counseling experience with a large Parkinson disease cohort is used as a starting point to question the state of clinical and nonclinical practice in disclosing this unusual connection We conclude that more research and discussion are needed to inform practice regarding the crossroads of Gaucher and Parkinson disease.

Entities:  

Keywords:  Gaucher disease; Genetic counseling; Parkinson disease

Mesh:

Substances:

Year:  2017        PMID: 28667566     DOI: 10.1007/s10897-017-0123-6

Source DB:  PubMed          Journal:  J Genet Couns        ISSN: 1059-7700            Impact factor:   2.537


  36 in total

1.  Screening for Gaucher disease: new challenges.

Authors:  Ari Zimran; Gheona Altarescu; Deborah Elstein
Journal:  Isr Med Assoc J       Date:  2014-11       Impact factor: 0.892

2.  Reliability of reported age at onset for Parkinson's disease.

Authors:  Carson R Reider; Cheryl A Halter; Peter F Castelluccio; David Oakes; William C Nichols; Tatiana Foroud
Journal:  Mov Disord       Date:  2003-03       Impact factor: 10.338

3.  Type 1 Gaucher disease: significant disease manifestations in "asymptomatic" homozygotes.

Authors:  Manisha Balwani; Laura Fuerstman; Ruth Kornreich; Lisa Edelmann; Robert J Desnick
Journal:  Arch Intern Med       Date:  2010-09-13

4.  Replacement therapy for inherited enzyme deficiency--macrophage-targeted glucocerebrosidase for Gaucher's disease.

Authors:  N W Barton; R O Brady; J M Dambrosia; A M Di Bisceglie; S H Doppelt; S C Hill; H J Mankin; G J Murray; R I Parker; C E Argoff
Journal:  N Engl J Med       Date:  1991-05-23       Impact factor: 91.245

5.  Occurrence of Parkinson's syndrome in type I Gaucher disease.

Authors:  O Neudorfer; N Giladi; D Elstein; A Abrahamov; T Turezkite; E Aghai; A Reches; B Bembi; A Zimran
Journal:  QJM       Date:  1996-09

6.  The incidence of Parkinsonism in patients with type 1 Gaucher disease: data from the ICGG Gaucher Registry.

Authors:  Barry Rosenbloom; Manisha Balwani; Jeff M Bronstein; Edwin Kolodny; Swati Sathe; Andrea R Gwosdow; John S Taylor; J Alexander Cole; Ari Zimran; Neal J Weinreb
Journal:  Blood Cells Mol Dis       Date:  2010-11-10       Impact factor: 3.039

7.  Gaucher disease: gene frequencies in the Ashkenazi Jewish population.

Authors:  E Beutler; N J Nguyen; M W Henneberger; J M Smolec; R A McPherson; C West; T Gelbart
Journal:  Am J Hum Genet       Date:  1993-01       Impact factor: 11.025

Review 8.  Gaucher disease: mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA).

Authors:  Kathleen S Hruska; Mary E LaMarca; C Ronald Scott; Ellen Sidransky
Journal:  Hum Mutat       Date:  2008-05       Impact factor: 4.878

9.  Gaucher disease with parkinsonian manifestations: does glucocerebrosidase deficiency contribute to a vulnerability to parkinsonism?

Authors:  N Tayebi; J Walker; B Stubblefield; E Orvisky; M E LaMarca; K Wong; H Rosenbaum; R Schiffmann; B Bembi; E Sidransky
Journal:  Mol Genet Metab       Date:  2003-06       Impact factor: 4.797

10.  Eliciting preferences on secondary findings: the Preferences Instrument for Genomic Secondary Results.

Authors:  Kyle B Brothers; Kelly M East; Whitley V Kelley; M Frances Wright; Matthew J Westbrook; Carla A Rich; Kevin M Bowling; Edward J Lose; E Martina Bebin; Shirley Simmons; John A Myers; Greg Barsh; Richard M Myers; Greg M Cooper; Jill M Pulley; Mark A Rothstein; Ellen Wright Clayton
Journal:  Genet Med       Date:  2016-08-25       Impact factor: 8.822

View more
  4 in total

Review 1.  GBA-Associated Parkinson's Disease and Other Synucleinopathies.

Authors:  Ziv Gan-Or; Christopher Liong; Roy N Alcalay
Journal:  Curr Neurol Neurosci Rep       Date:  2018-06-08       Impact factor: 5.081

Review 2.  Genetic Testing for Parkinson Disease: Are We Ready?

Authors:  Lola Cook; Jeanine Schulze; Catherine Kopil; Tara Hastings; Anna Naito; Joanne Wojcieszek; Katelyn Payne; Roy N Alcalay; Christine Klein; Rachel Saunders-Pullman; Tatyana Simuni; Tatiana Foroud
Journal:  Neurol Clin Pract       Date:  2021-02

Review 3.  Gaucher disease: Basic and translational science needs for more complete therapy and management.

Authors:  Gregory A Grabowski; Armand H M Antommaria; Edwin H Kolodny; Pramod K Mistry
Journal:  Mol Genet Metab       Date:  2020-12-29       Impact factor: 4.797

4.  Parkinson's disease in Gaucher disease patients: what's changing in the counseling and management of patients and their relatives?

Authors:  Maja Di Rocco; Alessio Di Fonzo; Antonio Barbato; Maria Domenica Cappellini; Francesca Carubbi; Fiorina Giona; Gaetano Giuffrida; Silvia Linari; Andrea Pession; Antonella Quarta; Maurizio Scarpa; Marco Spada; Pietro Strisciuglio; Generoso Andria
Journal:  Orphanet J Rare Dis       Date:  2020-09-23       Impact factor: 4.123

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.